← Stocks · OM record
Signal record & history · Trifecta Signals
Outset has been flagged by the Trifecta screener 9 times since 2022. 5 signals confirmed; the median confirmed signal is down 98.0% since its Early Signal.
Price refreshes every trading day after the close.
Full interactive chart ↗ · partner link
Daily closes · through the most recent close
Price history from Jan 2018 · Signal tracking began Jan 2022
Headline statistics: confirmed signals only, measured from the confirmation price.
First signal Jan 2022 · Latest Jan 2024 · Confirmed 5 of 9 Early · Latest close in the chart data: Wed, Nov 4, 2026
Groups are mutually exclusive — every confirmed signal sits in exactly one.
Since January 2022, Outset has had nine Early signals, five confirmed. Four of the five decided signals gained +10% within 90 days, and zero of five finished ahead of the S&P 500 since confirmation. Five signals carried a caution flag. Four Early signals never confirmed and count in no statistic.
Every Early signal in the record, newest first.
Members see every signal below, and the group mix above.
Membership unlocks the complete signal timeline for OM and every other stock in the record — group tags, caution flags, and the full screener.
Already a member? Sign in and this page unlocks.
Outset Medical is classified in the Healthcare sector, Medical Devices industry. With a market value of about $78 million, the company falls in the small-cap group.
Outset Medical’s standout Trifecta run followed a October 2022 confirmation, gaining about 56% over the next 90 days. Outset Medical’s April 2023 signal, which landed in the Downtrend group, rose about 15% over the following 90 days. Classification adds texture: its latest signal was rated Low Quality, revenue was growing by about 18% at the time, and it sat in the mid-cap group when that signal fired.
OM closed Wednesday, November 4 at $4.44, up 7.0% on the day. Over the past week, the shares have traded in a range between about $4.02 and $4.44.
